Search by Drug Name or NDC
NDC 64679-0631-02 Nicardipine Hydrochloride 2.5 mg/mL Details
Nicardipine Hydrochloride 2.5 mg/mL
Nicardipine Hydrochloride is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Wockhardt USA LLC.. The primary component is NICARDIPINE HYDROCHLORIDE.
Product Information
| NDC | 64679-0631 |
|---|---|
| Product ID | 64679-631_f69df5dd-4984-6d75-e053-6294a90ad4ff |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Nicardipine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Nicardipine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 2.5 |
| Active Ingredient Units | mg/mL |
| Substance Name | NICARDIPINE HYDROCHLORIDE |
| Labeler Name | Wockhardt USA LLC. |
| Pharmaceutical Class | Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA090671 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 64679-0631-02 (64679063102)
| NDC Package Code | 64679-631-02 |
|---|---|
| Billing NDC | 64679063102 |
| Package | 10 VIAL, SINGLE-DOSE in 1 CARTON (64679-631-02) / 10 mL in 1 VIAL, SINGLE-DOSE (64679-631-03) |
| Marketing Start Date | 2009-11-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |